title: Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer: results from a phase 2 trial.
authors.affiliation: Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA. garciaj4@cff.org
authors.forename: Jorge A
authors.initials: JA
authors.lastname: Garcia
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Hutson
authors.forename: Dale
authors.initials: D
authors.lastname: Shepard
authors.forename: Paul
authors.initials: P
authors.lastname: Elson
authors.forename: Robert
authors.initials: R
authors.lastname: Dreicer